The transgenic construct contains the reverse tetracycline-controlled transactivator (rtTA*M2) protein under the control of the 13Kb (7.3kb upstream of, and 5.7kb downstream of the transcription start site) mouse villin 1 promoter. Founder line 3(V3) expression is observed in the intestinal villi. (J:211832)